Fmstrat

@Fmstrat@lemmy.world · Joined ⁨Apr⁩ ⁨2024⁩

Replying to @⁨Axolotl_cpp@feddit.it⁩

Not true. Veracrypt’s hidden file system is random data on a preexisting partition that uses no software. You can only detect it if you install Veracrypt and guess the password.

veracrypt.io/en/Hidden Volume.html

veracrypt.ioVeraCrypt - Free Open source disk encryption with strong security for the ParanoidVeraCrypt is free open-source disk encryption software for Windows, Mac OS X and Linux. In case an attacker forces you to reveal the password, VeraCrypt provides plausible deniability. In contrast to file encryption, data encryption performed by VeraCrypt is real-time (on-the-fly), automatic, transparent, needs very little memory, and does not involve temporary unencrypted files.

Replying to @⁨teolan@lemmy.world⁩

My understanding from other articles is caller satisfaction is greater with the TTS system, and it uses voice IVR to triage of they have additional information. AI is not bullshit in and of itself. This product seems barely diffeent from what they provided with APEX.

Recordings also can’t auto respond with updates to the caller like this can, which is a pretty nice feature, even if it’s just TTS.

Replying to @⁨sanitation@lemmy.today⁩

Everyone should read before reacting:

This is intended to handle the increase of calls that are related to one incident, so callers get automatically routed to an AI agent who asks if they are calling regarding the incident. If the answer is yes, then callers can receive information or updates, and if it’s no, then the callers are transferred to a human.

This makes sense. A big thing happens that you are aware of. Geolocated calls from that area flood in. An operator, who could be getting useful info, has to handle a flood of “Guess what I just saw!”

Note that I think they should spend the money on more operators instead, but at least this seems like it has good guardrails.

Replying to @⁨SaveTheTuaHawk@lemmy.ca⁩

pmc.ncbi.nlm.nih.gov/articles/PMC10835503/

Safety testing on humans (P1) is complete. No efficacy measures in the study, but that’s not out of the norm for P1.

PubMed Central (PMC)Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL‐286, a novel retinoic acid receptor‐β agonist for treatment of spinal cord injury, in male healthy participantsKCL‐286 is an orally available agonist that activates the retinoic acid receptor (RAR) β2, a transcription factor which stimulates axonal outgrowth. The investigational medicinal product is being developed for treatment of spinal cord injury (SCI). ...